Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Institutional Investors in Europe

Hi Angela,

What significance does yesterday’s press release have on the domestic validity of the MMP? Can Patriot/TPL now target all German infringers? What about other members of the EU, are they fair game as well?

Please advise.

Hi, XXXX

We are analyzing the information we have available on the ruling, and will share what we are able to without providing competitive information or speculating on the impact the ruling might have on the USPTO activities.

Best regards,

Angela Hartley

Investor Relations

Share
New Message
Please login to post a reply